Effects of Empagliflozin in Reducing Oxidative Stress After Kidney Transplantation

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

July 5, 2025

Study Completion Date

August 5, 2025

Conditions

Kidney Transplant; Complications

Interventions

DRUG

Empagliflozin 25 MG

25 mg

DRUG

Insulin

Trial Locations (2)

Labbafinezhd Hospital, Tehran

SBMU, Tehran

All Listed Sponsors

lead

Shahid Beheshti University of Medical Sciences

OTHER

NCT04918407 - Effects of Empagliflozin in Reducing Oxidative Stress After Kidney Transplantation | Biotech Hunter | Biotech Hunter